Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $117.19 million. The enterprise value is -$69.04 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRBU has 93.00 million shares outstanding. The number of shares has increased by 12.77% in one year.
Current Share Class | 93.00M |
Shares Outstanding | 93.00M |
Shares Change (YoY) | +12.77% |
Shares Change (QoQ) | +1.67% |
Owned by Insiders (%) | 4.70% |
Owned by Institutions (%) | 53.29% |
Float | 83.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.58 |
Forward PS | 13.76 |
PB Ratio | 0.54 |
P/TBV Ratio | 0.54 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.12.
Current Ratio | 7.63 |
Quick Ratio | 7.41 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.76% and return on invested capital (ROIC) is -32.38%.
Return on Equity (ROE) | -52.76% |
Return on Assets (ROA) | -29.21% |
Return on Invested Capital (ROIC) | -32.38% |
Return on Capital Employed (ROCE) | -64.87% |
Revenue Per Employee | $67,469 |
Profits Per Employee | -$1.01M |
Employee Count | 147 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -9,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.57% in the last 52 weeks. The beta is 2.44, so CRBU's price volatility has been higher than the market average.
Beta (5Y) | 2.44 |
52-Week Price Change | -40.57% |
50-Day Moving Average | 0.90 |
200-Day Moving Average | 1.54 |
Relative Strength Index (RSI) | 64.54 |
Average Volume (20 Days) | 1,125,713 |
Short Selling Information
The latest short interest is 9.49 million, so 10.21% of the outstanding shares have been sold short.
Short Interest | 9.49M |
Short Previous Month | 7.63M |
Short % of Shares Out | 10.21% |
Short % of Float | 11.31% |
Short Ratio (days to cover) | 9.22 |
Income Statement
In the last 12 months, CRBU had revenue of $9.92 million and -$147.86 million in losses. Loss per share was -$1.62.
Revenue | 9.92M |
Gross Profit | -119.76M |
Operating Income | -159.03M |
Pretax Income | -123.25M |
Net Income | -147.86M |
EBITDA | -154.65M |
EBIT | -159.03M |
Loss Per Share | -$1.62 |
Full Income Statement Balance Sheet
The company has $208.47 million in cash and $26.22 million in debt, giving a net cash position of $186.23 million or $2.00 per share.
Cash & Cash Equivalents | 208.47M |
Total Debt | 26.22M |
Net Cash | 186.23M |
Net Cash Per Share | $2.00 |
Equity (Book Value) | 217.22M |
Book Value Per Share | 2.34 |
Working Capital | 188.83M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$137.72 million and capital expenditures -$4.47 million, giving a free cash flow of -$142.20 million.
Operating Cash Flow | -137.72M |
Capital Expenditures | -4.47M |
Free Cash Flow | -142.20M |
FCF Per Share | -$1.53 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,603.42% |
Pretax Margin | -1,490.94% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.77% |
Shareholder Yield | -12.77% |
Earnings Yield | -126.18% |
FCF Yield | -121.34% |
Analyst Forecast
The average price target for CRBU is $8.50, which is 574.60% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.50 |
Price Target Difference | 574.60% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 171.34% |
EPS Growth Forecast (5Y) | -13.58% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -1.49 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.49 |
Piotroski F-Score | 1 |